Perspectives in adjuvant chemotherapy in NSCLC. - Wikidata - awgldk - TriplyDB

Perspectives in adjuvant chemotherapy in NSCLC.

Perspectives in adjuvant chemotherapy in NSCLC.

http://www.wikidata.org/entity/Q43061648

about

Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: an east asian population-based study

P2860

Q36349601-375571C7-6087-4CC3-88A5-86510F1CE925

P2860

Perspectives in adjuvant chemotherapy in NSCLC.

http://www.wikidata.org/entity/Q43061648

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Perspectives in adjuvant chemotherapy in NSCLC.

@en

Perspectives in adjuvant chemotherapy in NSCLC.

@nl

type

label

Perspectives in adjuvant chemotherapy in NSCLC.

@en

Perspectives in adjuvant chemotherapy in NSCLC.

@nl

prefLabel

Perspectives in adjuvant chemotherapy in NSCLC.

@en

Perspectives in adjuvant chemotherapy in NSCLC.

@nl

P1433

Q43061648-8788F4B2-2700-45B3-A345-F9CAC79C2E7A

P1476

Q43061648-E40A2F91-4726-45CD-980A-00FE4EB0C1F7

P2093

Q43061648-D17DCABE-6204-4FE6-8DCC-346F22ABFA98

Q43061648-DB045490-8BBA-4987-BE1B-94F34A6FD10E

P2860

Q43061648-00972F2A-414A-47A8-A210-235E52053B00

Q43061648-041E1792-351E-4B56-81D8-A93C57D09CEB

Q43061648-054529A3-6328-47C5-BEEF-1A2CE27D9A18

Q43061648-0A46B770-0DC3-4CA1-A9D6-FCB85FA77E1F

Q43061648-0C4073DF-5261-4634-8BA6-2C95EDC2E99E

Q43061648-12C13FED-4AD6-4238-85EB-D81198E1368D

Q43061648-193EB6E6-64C6-41C6-8D19-9D51D15FE813

Q43061648-1BF5DCAB-C560-474A-A63F-26876B7AA4E0

Q43061648-2A6B1AB5-7A0D-4D4B-B947-69F51087C92C

Q43061648-2B0F46F6-63C7-4D3B-B9C3-E003F7564618

P304

Q43061648-6FD670BC-9A98-44A0-B428-C9B90580D968

P31

Q43061648-F0B8121B-4B10-4FF4-AA7B-668AC4A5BDFE

P356

Q43061648-E881373C-073C-49E0-83F3-EF98769CF3D1

P433

Q43061648-1760384E-CD7D-4DC1-8CC3-F84351693D8A

P478

Q43061648-08268B83-07A0-4A2C-A0C5-4971EB167C5C

P577

Q43061648-163034A3-920B-41A5-B548-B031B320827D

P698

Q43061648-2767DA4C-7225-4A70-8626-CBBA026A19C1

P356

17476348.1.1.99

P1433

Expert Review of Respiratory Medicine

P1476

Perspectives in adjuvant chemotherapy in NSCLC.

@en

P2093

Giorgio Vittorio Scagliotti

http://www.w3.org/2001/XMLSchema#string

Giovanni Selvaggi

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Global cancer statistics, 2002

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Revisions in the International System for Staging Lung Cancer

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Lung cancer in never smokers: a review

Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial

P304

99-110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17476348.1.1.99

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20477270

http://www.w3.org/2001/XMLSchema#string